Actively Recruiting
Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders
Led by Universitat Jaume I · Updated on 2025-05-16
158
Participants Needed
1
Research Sites
139 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to develop and test the efficacy of first-of-its-kind, fully instrumented sensor-based smartphone-guided in-vivo exposure therapy using a just-in-time intervention for anxiety disorder. The main hypotheses are: 1. Both treatment conditions (CBT treatment with IVE and CBT treatment with IVE+SYMPTOMS-JIT) will show efficacy and no statistically significant differences will be found between them. The efficacy will be determined for the differences in pre-post treatment in the used outcome measures. 2. The therapeutic gains obtained in both treatment conditions (IVE and (IVE+SYMPTOMS-JIT) will be maintained at 1-, 6-, and 12-month follow-up periods. 3. Both treatment conditions will be efficient, that is, they will be well-valued by patients and therapists. However, IVE+SYMPTOMS-JIT will be preferred and perceived as less aversive than IVE. 4. The main barriers for the use of this technology are not technological, but rather attitudinal and they can be identified through qualitative studies.
CONDITIONS
Official Title
Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be at least 18 years old
- Have a diagnosis of anxiety disorder including specific phobia, agoraphobia, panic disorder, or social anxiety disorder according to DSM-5
- Be willing to follow the study procedures
- Sign the consent form
You will not qualify if you...
- Have another psychological problem needing immediate attention
- Have current alcohol or drug dependence, abuse, psychosis, or severe organic illness
- Be currently treated in a similar therapy program
- Use anxiolytic medications or plan to change their dose during the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Jaume I
Castellon, Castellón, Spain, 12071
Actively Recruiting
Research Team
I
Iratxe Alonso-Olea, Phd Student
CONTACT
J
Juana María Bretón-López, Lecturer
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here